Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively

Trial Identifier: GRC00097
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: September 2019
Primary Completion Date: December 2019
Study Completion Date: December 2019
Condition: Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Kentucky Bardstown, Kentucky, United States, 40004
United States, Utah Salt Lake City, Utah, United States, 84121